May 13, 2025
achondroplasia treatment

“Achondroplasia Treatment Market Poised to Witness High Growth owing to Increasing Disease Prevalence

The achondroplasia treatment market is primarily driven by the growing prevalence of achondroplasia disease globally. Achondroplasia is the most common form of genetic skeletal dysplasia and disproportionate short stature in humans. The growing awareness about the disease and its treatment options along with the introduction of novel treatment therapies by key players are fueling the growth of the market. According to research studies, achondroplasia affects approximately 1 in every 15,000-40,000 newborns worldwide.

The Global achondroplasia treatment market is estimated to be valued at US$ 147.23 Bn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period between 2024 to 2031.

Key players operating in the achondroplasia treatment market are Salesforce.com, Inc., Microsoft Corporation, ADOBE INC., SAP SE, Oracle Corporation, SugarCRM Inc., Zoho Corporation Pvt. Ltd, Copper CRM, Inc., Insightly Inc., and Creatio. These players are focusing on developing advanced treatment therapies and expanding their geographical presence globally. For instance, in 2021 Insightly Inc launched a new advanced CRM platform to cater the needs of achondroplasia patients and healthcare organizations.

Key opportunities in the market include growing research and development activities for novel therapies, increasing adoption of personalized medicine approach for Achondroplasia Treatment Market and favorable regulatory framework. Major companies are focusing on mergers and acquisitions to strengthen their product pipeline and expand globally. For example, in 2022, Salesforce.com acquired Vlocity to expand its industry-specific cloud and data platform.

Owing to increasing burden of achondroplasia, companies are focusing on developing drugs for emerging economies including Asia Pacific and Latin America. Countries like China, India, Brazil, Mexico are providing lucrative opportunities for key players on account of rising healthcare expenditure, growing medical tourism and increasing awareness.

The increasing disease prevalence across the globe is a major market driver. It is estimated that achondroplasia affects 1 in every 10,000 to 30,000 newborns worldwide. Favorable government policies and regulatory framework in developing countries is also encouraging more investments in this sector.

PEST Analysis

POLITICAL: Regulations regarding drug approval and pricing are major considerations in the Achondroplasia treatment market. Changes in healthcare reimbursement policies may impact demand.

ECONOMIC: Rising healthcare spending and increasing public awareness about the condition are fueling market growth. However, high costs of treatments may restrain the market to some extent.

SOCIAL: Social stigma and lack of confidence associated with short stature are key factors driving patients to seek treatment. Patient support groups also influence treatment-seeking behavior.

TECHNOLOGICAL: Advancements in genetic analysis and gene therapy offer potential treatment options. Development of customized drugs capable of targeting the root cause at the genetic level could transform the landscape in the coming years. Delivery mechanisms of therapeutics are also undergoing refinement.

The North American region currently holds the largest share of the Achondroplasia treatment market in terms of value. This can be attributed to factors such as high adoption of advanced treatment methods, growing healthcare expenditure, and favorable reimbursement structures in countries like the US and Canada.

The Asia Pacific region is projected to witness the fastest growth over the forecast period. This can be accredited to rising income levels, growing medical tourism industry, increasing investments by pharmaceutical companies, and expanding healthcare infrastructure in emerging nations.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it

Ravina
+ posts

Ravina Pandya, a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals. 

Ravina Pandya

Ravina Pandya, a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals. 

View all posts by Ravina Pandya →